{"adverse_reactions":["• ADVERSE EVENTS To facilitate Adverse Event Reporting: www.fda.gov/medwatch or 1-800-FDA-1088."],"dosage_and_administration":["• DOSAGE AND ADMINISTRATION. FOR INTRAVENOUS USE ONLY. PRESERVATIVE-FREE INJECTION SOLUTION."],"dosage_forms_and_strengths":["• INGREDIENTS Each 1 mL contains the equivalent of 32 mcg norepinephrine base, 50 mg dextrose, 236.8 mcg sodium chloride, 64 mcg sodium metabisulfite, and pH adjusters include hydrochloric acid and/or sodium hydroxide, if necessary."],"effective_time":"20150306","how_supplied":["• HOW SUPPLIED Norepinephrine bitartrate injection solution is supplied as a sterile, nonpyrogenic solution that is clear, colorless at 250 mL in a Single-Dose Injection Solution Bag. This product is Preservative-Free and Latex-Free."],"id":"6dda258a-0665-4eb5-a422-cf4d2240f4f1","openfda":{},"package_label_principal_display_panel":["Label"],"set_id":"997f00c2-affb-4af1-bdff-7ceb418df696","spl_product_data_elements":["Norepinephrine Bitartrate Norepinephrine Bitartrate Norepinephrine Bitartrate Norepinephrine ANHYDROUS DEXTROSE SODIUM CHLORIDE SODIUM METABISULFITE WATER HYDROCHLORIC ACID SODIUM HYDROXIDE"],"spl_unclassified_section":["Rx Only Rev. 03/15 CANTRELL DRUG COMPANY LITTLE ROCK, AR 72207"],"storage_and_handling":["• STORAGE AND HANDLING Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature]. Protect from light. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to use, whenever solution and container permit. Do not use the solution if its color is pinkish or darker than slightly yellow or if it contains a precipitate."],"version":"1","warnings_and_cautions":["• WARNINGS AND PRECAUTIONS Outsourced Compounded Drug. Not for Resale. Hospital/Office Use Only."]}